文献速递心胸血管麻醉

心脏手术阿片类药物剂量差异:多中心实践研究

Opioid Dose Variation in Cardiac Surgery: A Multicenter Study of Practice.
PubMed 文献 · Anesth Analg · 2025-01-01

本研究基于多中心围术期结局组注册数据,回顾2014至2021年30家医院59,463例成人心脏手术,术中阿片剂量以芬太尼当量计。结果显示平均剂量为1139 μg(95%CI 1132-1146),剂量变异大(SD 872 μg),60%的变异可由医院和麻醉医师解释,提示实践差异而非患者或手术因素是变异主要来源。

要点

  • 心脏手术阿片剂量高且变异大,平均1139 μg芬太尼当量。
  • 60%的剂量变异归因于医院和麻醉医师的实践差异。
  • 麻醉医师阿片剂量与舒芬太尼输注频率强相关(r=0.81)。

核心结论

  • 高剂量阿片类药物在心脏手术中占主导,病例间剂量差异大,大部分变异归因于实践差异而非患者或手术差异。

研究设计与样本

  • 回顾性多中心队列研究,纳入2014至2021年30家学术和社区医院中需体外循环的非急诊成人心脏手术,共59,463例,使用分层线性模型分析剂量变异来源。

主要发现

  • 患者平均接受1139 μg芬太尼当量(95%CI 1132-1146),标准差872 μg。
  • 最常用阿片为芬太尼(86%)、舒芬太尼(16%)、氢吗啡酮(12%)和吗啡(3%),0.6%病例无阿片。
  • 60%的剂量变异可由医院和麻醉医师解释。
  • 随机选取的两名麻醉医师间阿片剂量中位差异为600 μg芬太尼(IQR 283-1023 μg)。
  • 麻醉医师术中阿片剂量与其舒芬太尼输注频率强相关(r=0.81),与非阿片镇痛技术使用弱相关(|r|<0.3)。

临床怎么用

  • 心脏手术麻醉中阿片剂量存在显著实践差异,提示可优化阿片使用,但需结合患者个体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although high-opioid anesthesia was long the standard for cardiac surgery, some anesthesiologists now favor multimodal analgesia and low-opioid anesthetic techniques. The typical cardiac surgery opioid dose is unclear, and the degree to which patients, anesthesiologists, and institutions influence this opioid dose is unknown. METHODS: We reviewed data from nonemergency adult cardiac surgeries requiring cardiopulmonary bypass performed at 30 academic and community hospitals within the Multicenter Perioperative Outcomes Group registry from 2014 through 2021. Intraoperative opioid administration was measured in fentanyl equivalents. We used hierarchical linear modeling to attribute opioid dose variation to the institution where each surgery took place, the primary attending anesthesiologist, and the specifics of the surgical patient and case. RESULTS: Across 30 hospitals, 794 anesthesiologists, and 59,463 cardiac cases, patients received a mean of 1139 (95% confidence interval [CI], 1132-1146) fentanyl mcg equivalents of opioid, and doses varied widely (standard deviation [SD], 872 µg). The most frequently used opioids were fentanyl (86% of cases), sufentanil (16% of cases), hydromorphone (12% of cases), and morphine (3% of cases). 0.6% of cases were opioid-free. 60% of dose variation was explainable by institution and anesthesiologist. The median difference in opioid dose between 2 randomly selected anesthesiologists across all institutions was 600 µg of fentanyl (interquartile range [IQR], 283-1023 µg). An anesthesiologist's intraoperative opioid dose was strongly correlated with their frequency of using a sufentanil infusion (r = 0.81), but largely uncorrelated with their use of nonopioid analgesic techniques (|r| < 0.3). CONCLUSIONS: High-dose opioids predominate in cardiac surgery, with substantial dose variation from case to case. Much of this variation is attributable to practice variability rather than patient or surgical differences. This suggests an opportunity to optimize opioid use in cardiac surgery.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Fisher C, Janda AM, Zhao X, et al. Opioid Dose Variation in Cardiac Surgery: A Multicenter Study of Practice. Anesth Analg. 2025. PMID: 39167548. doi:10.1213/ANE.0000000000007128

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。